A comparative assessment of RBP4 expression, clinicopathological features, and HCC-patient outcomes has also indicated that RBP4 may be a contributing factor linked to the metabolic microenvironment of HCC [26,27]. This evidence concerns the gene RBP4 and hepatocellular carcinoma.